We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byJohn Tucker
Modified over 3 years ago
MCV THE EVOLUTION OF EVH AND CONDUIT QUALITY
MCV © MAQUET2 EVH: THE STANDARD OF CARE Highly evolved systems, developed over the past 15 years Eight generations of devices, along with accessory line, have been introduced Product features, harvester training and understanding of physiological mechanisms affecting graft patency has significantly improved Emphasis on conduit quality and patient outcomes
MCV © MAQUET3 EVH: THEN & NOW 1995: EVH was an innovative alternative to invasive open surgery Today, 95% of U.S. hospitals use EVH Successes supported by 15 years of peer-reviewed, randomized studies Over 1 million EVH procedures performed worldwide 2008 STS Floor Survey and market research data on file. MAQUET Cardiovascular. 2008
MCV © MAQUET4 EVH: THE EARLY YEARS Tenfold increase in procedures Clear patient benefits 2008 STS Floor Survey and market research data on file. MAQUET Cardiovascular. 2008
MCV © MAQUET5 EVH: 1999–2000 Reduced patient complications No histological difference between EVH and open vessel harvesting Yun KL, et al. Randomized trial of endoscopic versus open vein harvest for coronary artery bypass grafting: six-month patency rates. J Thorac Cardiov Surg. 2005;129: Davis Z, et al. Endoscopic vein harvest for coronary artery bypass grafting: technique and outcomes. J Thorac Cardiov Surg. 1998;116: Allen KB, et al. Endoscopic versus traditional saphenous vein harvesting: a prospective, randomized trial. Ann Thorac Surg. 1998;66: Kan CD, et al. Endoscopic saphenous vein harvest decreases leg wound complications in coronary artery bypass grafting patients. J Cardiac Surg. 1999;1: Crouch JD, et al. Open versus endoscopic saphenous vein harvesting: wound complications and vein quality. Ann Thorac Surg. 1999;68: Carpino PA, et al. Clinical benefits of endoscopic vein harvesting in patients with risk factors for saphenectomy wound infections undergoing coronary artery bypass grafting. J Thorac Cardiov Surg. 2000;119: Patel AN, et al. Prospective analysis of endoscopic vein harvesting. Am J Surg. 2002;73: Bitondo JM, et al. Endoscopic versus open saphenous vein harvest: a comparison of postoperative wound complications. Ann Thorac Surg. 2002;73:
MCV © MAQUET6 EVH: 2003–2005 No significant difference in event-free survival over a 5-year follow-up period 1 Largest prospective randomized angiographic study of EVH versus open vessel harvesting: no compromoise in 6- month patency rate : ISMICS recognizes EVH as The Standard of Care for vessel harvesting for patients undergoing CABG surgery 3 1. Allen KB, et al. Influence of endoscopic versus traditional saphenectomy on event-free survival: five-year follow-up of a prospective randomized trial. Heart Surg Forum. 2003;6:E Yun KL, et al. Randomized trial of endoscopic versus open vein harvest for coronary artery bypass grafting: six-month patency rates. J Thorac Cardiov Surg. 2005;129: Allen KB, et al. Endoscopic Vascular Harvest in Coronary Artery Bypass Grafting Surgery: A Consensus Statement of the International Society of Minimally Invasive Cardiothoracic Surgery (ISIMICS) Innovations: Technology & Techniques in Cardiothoracic & Vascular Surgery. Winter 2005;1:51-60.
MCV © MAQUET7 EVH: 2006–2009 Low-dose heparin bolus associated with: – Four-fold reduction in graft failure – Reduction in incidence and volume of residual clot strands Use of heparin is associated with improved patency in saphenous vein grafts Poston RS, et al. Heparin Administration Prior to Endoscopic Vein Harvest Limits Clot Retention and Improves Graft Patency. Abstract. ISMICS. June 8, Pre-heparinization gains adoption as EVH best practice
MCV © MAQUET8 EVH: 2009–2010 Endothelial injury found to decrease long-term graft patency 1, 2 – Preventing overdistension with pressure control – Limiting thermal spread to <1 mm VASOSHIELD Pressure Controlling Syringe controls vessel distension VASOVIEW HEMOPRO pre-clinical study demonstrates mean thermal spread of 0.19 mm 3 VASOVISION Endoscopic Visualization System 1. Thatte HS, et al. The coronary bypass conduit: I. Intraoperative endothelial injury and its implication on graft patency. Ann Thorac Surg. 2001; 72: S Angelini GD, et al. Metabolic damage to human saphenous vein graft during preparation for coronary artery bypass grafting. Cardiovasc Res. 1985; 19: Lombardi P. Measurement of thermal spread from use of VASOVIEW® HEMOPRO: study demonstrates minimal thermal injury to endothelium. San Jose, CA MAQUET Cardiovascular; Increased focus on need to optimize conduit quality
MCV © MAQUET9 EVH – KEY LEARNINGS FROM EXPERIENCE Meticulous vein handling protects endothelial integrity Pre-heparinization has significant clinical benefits Product ergonomics, control and precision matter On-going harvester training and support is an important factor for success
MCV TRAINING BUILDS EVH STRENGTH Optimizing techniques helps improve harvester success MAQUET Program Resources: Clinical Expertise Available Global Sites for Hands-on Opportunities Visiting Clinical Ambassadors from U.S. Classroom/Workshop events Leg model practice © MAQUET10
MCV © MAQUET MAQUET Cardiovascular is committed to EVH technology Continue to refine the market leading VASOVIEW platform Focus and investment in the field of cardiac surgery Focused on improving patient outcomes Close collaboration and partnership with practicing clinicians in the development of next generation products and innovations A PROMISING FUTURE 11 MCV
M Gaudino. 2 Loop FD et al NEJM 1986 Arterial conduits used for coronary artery bypass grafting - Internal Thoracic Artery - Radial Artery - Right.
CHANGING WORLDS The Impact of University Research.
Date of download: 9/19/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association Between Endoscopic vs Open Vein-Graft.
Lund – Malmö, SWEDEN. Is the Era of Off-pump Surgery over? ARASH MOKHTARI, MD, PHD.
Lucia Torracca Tenth International Symposium HEART FAILURE & Co. CARDIOLOGY SCIENCE UPDATE FEMALE DOCTORS SPEAKING ON FEMALE DISEASES Milano aprile.
Configurations of Arterial Grafts : When to use a SV Graft Joseph F. Sabik, MD Chairman and Professor of Surgery Department of Thoracic and Cardiovascular.
Randomized Controlled Trial of Intensive Versus Conservative Glucose Control in Patients Undergoing Coronary Artery Bypass Graft Surgery: GLUCOCABG Trial.
STS 2015 John V. Conte, MD Professor of Surgery Johns Hopkins University School of Medicine On Behalf of the CoreValve US Investigators Transcatheter Aortic.
Off pump CABG has been performed for the first time 40 years ago. Although conventional CABG is considered both safe and effective, the use of CBP.
Steve Goldman, M.D. ClinicalTrials.gov number, NCT
Presenter Name(s) Issue date National Student.
Infrapopliteal Sirolimus-Eluting Versus Bare Metal Stents for Critical Limb Ischemia: Long-Term Angiographic and Clinical Outcome in >100 Patients Dimitris.
A Clinical Evaluation of Terumo’s Prescriptive Oxygenation™ Series Capiox® FX15 and FX25 Hollow Fiber oxygenators with Integrated Arterial Filter in the.
Pexelizumab for the Reduction of Infarction and Mortality in Coronary Artery Bypass Graft ll (PRIMO-CABG II) Trial Presented at The American College of.
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Year in Cardiovascular Surgery J Am Coll Cardiol.
HEART TRANSPLANTATION Pediatric Recipients ISHLT 2005 J Heart Lung Transplant 2005;24:
Does a Preservation Solution for Vascular Grafts Matter?
New guidelines for CABG Kim Eagle, MD Director of Clinical Cardiology University of Michigan at Ann Arbor Ann Arbor, MI.
Page 1IASI, October 2009Dominique Schwarz 11,20 8,80 5,5,1 4,4 1,2 1,6 8,0 8,6 11,60 6,71 11,89 Hybrid Operating Room IASI, 2009 Dominique SchwarzSiemens.
BY Dr. Khaled Helmy Al Mahmora Chest Hospital BY Dr. Khaled Helmy Al Mahmora Chest Hospital Treatment Of Hypertension In Diabetes.
Cardiac Risk In ESRD Patient DR.BADR ALHOMAYEED.MD NEPHROLOGY AND KIDNEY TRANSPLANT CONSULTANT FEB/8/2014.
HEART TRANSPLANTATION Pediatric Recipients ISHLT 2007 J Heart Lung Transplant 2007;26:
A few basics of cardiac surgery…. Brett Sheridan, MD Assistant Professor Department of Surgery.
HEART TRANSPLANTATION Pediatric Recipients ISHLT 2008 J Heart Lung Transplant 2008;27:
Dr.Mohammad foudazi Research center of endoscopic surgery, Iran medical university.
The GREAT Trial. The Grampian Region Early Anistreplase Trial Reference Zahringer M, Sapoval M, Pattynama PM, et al. Sirolimus-eluting versus bare-metal.
G. Rainey Williams Symposium September 30, 2005 CABG in the Elderly Patient: On or Off pump? A Single Center Experience R. Nathan Grantham, M.D.
DHHS / FDA / CDRH 1 Trial Design Issues Associated with Evaluation of Distal Protection Devices in Diseased Saphenous Vein Grafts Bram D. Zuckerman, MD,
Creating Value with a da Vinci Surgery Program Presenter Name Presenter Title.
Ischemia Management with Accupril Post Bypass Graft via Inhibition of Angiotensin Converting Enzyme IMAGINEIMAGINE Presented at The European Society of.
Prosthesis-Patient Mismatch in High Risk Patients with Severe Aortic Stenosis in a Randomized Trial of a Self-Expanding Prosthesis George L. Zorn, III.
NAPLES Novel Approaches for Preventing or Limiting Event Study Randomised Comparison of Bivalirudin Monotherapy versus Unfractionated Heparin plus Tirofiban.
Hiroshima, Japan), 2010 and July 2012, the new shunt tube was used in 100 consecutive patients undergoing OPCABG new coronary shunt tube was easily.
Studies of the perception of the caring behaviors by nurses and patients in perioperative area and its implications for Evidence Based Practice.
MINIMALLY INVASIVE AORTIC VALVE REPLACEMENT ANTONIO MICELI DEPARTMENT OF CARDIOTHORACIC SURGERY FONDAZIONE TOSCANA G. MONASTERIO MASSA, ITALY.
Ischemic heart disease Basic Science 3/15/06. All of the following concerning coronary artery anatomy are correct except: The left main coronary artery.
Impact of Preoperative Renal Dysfunction in Patients Undergoing Off- pump vs On-pump Coronary Artery Bypass.
Surgical Risk Dr Chris Snowden MD FRCA Consultant Anaesthetist Freeman Hospital Newcastle upon Tyne.
How Many Arterial Grafts is Enough? Bruce Lytle MD Baylor Plano Heart Hospital.
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Coronary Artery Disease in Diabetic Patients, Different from Non-diabetics?
Does amiodarone work in prevention of postoperative AF for patients with CAD s/p CABG? 麻醉科 R1 楊美惠 麻醉科 R1 楊美惠.
Cardiovascular Disease in Women Module V: Prognosis and Treatment Outcomes.
Progress in Vascular Anesthesiology Donald M. Voltz, M.D. Assistant Professor of Anesthesiology Case Western Reserve University/University Hospitals of.
HEARTSTRING TM Proximal Seal System. CABG is associated with post-op neurocognitive dysfunction Dysfunction present in up to 80-90% at discharge, and.
Mitral Valve Peravalvular (Periprosthetic) Leak. Incidence of Mitral Valve Peravalvular Leak u Reported frequency of % after mitral valve replacement.
Secondary Prevention Following Coronary Artery Bypass Grafting: are we Compliant with the Guidelines? V. Joshi, B. Bridgewater University Hospital of South.
Direct Stenting is Better (Debate Session) 동아의대 김 무 현.
On Pump Coronary Artery Bypass Grafting (CABG) v. Off Pump CABG David Kim Independent Research GT.
Professor Martin T Rothman Director Cardiac Research & Development Barts & The London NHS Trust London, England Professor Martin T Rothman Director Cardiac.
© 2017 SlidePlayer.com Inc. All rights reserved.